Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02408861
Recruitment Status : Recruiting
First Posted : April 6, 2015
Last Update Posted : October 21, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)